Abstract
Parenteral nutrition (PN) is a lifesaving or life-sustaining treatment, but complications from its use, including central line-associated bloodstream infections (CLABSIs), necessitate that care be taken to ensure its safety. Our institution developed strategies that aim to incorporate evidence-based practices to reduce the risk of CLABSIs in patients receiving PN. A retrospective evaluation was conducted to assess the implementation of these strategies. Overall, adherence to the risk-reduction strategies was high, and no patients receiving PN experienced CLABSI during the time of the study.